Erectile function after WST11 vascular-targeted photodynamic therapy for low-risk prostate cancer treatment.
Vascular-targeted photodynamic therapy (VTP) using padeliporfin is currently assessed as a low-risk prostate cancer (LRPCa) treatment.
- Ref: Asian J Androl. 2020 Sep-Oct;22(5):454-458.
- Année de publication : 2020
- Auteurs : Chelly S, Maulaz P, Bigot P, Azzouzi AR, Lebdai S.
- Réseaux : Réseaux: « Cancers des Tissus Hormono-dépendants »